Colgate-Palmolive Company (CL)
Colgate-Palmolive (CL) Earnings Expected to Grow: Should You Buy?
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Colgate Advances 13% in a Year: To Buy or Not to Buy the Stock?
CL's solid pricing strategies and premium innovation drive growth, but macroeconomic challenges and currency headwinds warrant cautious optimism.
Crest, Colgate lawsuits target fluoride in kids' toothpaste, mouth rinse
Procter & Gamble and Colgate-Palmolive are among the defendants in six new lawsuits targeting the sale of toothpaste and mouth rinse for young children because the products contain fluoride, which can be harmful if swallowed.
3 Defensive Picks to Add Stability to Your Portfolio
As of January 9, 2025, the New York Fed's model to predict the likelihood of a recession suggests there is a 29% chance the U.S. will enter a recession sometime in 2025. This figure is down sharply from just two years ago, when the model—which makes predictions based yield spreads between 3-month T-bills and 10-year Treasury bonds—gave a 70% chance of a recession.
3 Ultra-Reliable Dividend King Stocks That Should Increase Their Payouts to All-Time Highs in 2025, Even if There's a Stock Market Sell-Off
When the S&P 500 is roaring higher, it's easy to overlook the benefits of investing in hihg-quality, dividend-paying companies. After all, a 2%, 3%, or even 4% dividend yield doesn't look impressive relative to a 23.3% gain -- which we saw from the S&P 500 in 2024.
CL's Pricing & Productivity Efforts Seem Encouraging: Apt to Hold?
Colgate benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
5 Staple Stocks to Watch in 2025 Amid Shifting Consumer Trends
As consumer preferences continue to evolve toward health and value-driven purchases, TSN, STZ, FRPT, PG and CL are well-placed for growth in 2025.
Colgate-Palmolive: Digital Advertising Is The Base From Which To Start Again
Colgate-Palmolive's (CL) revenue growth has been minimal over the past decade, with a CAGR of only 1.53%, not even keeping pace with inflation. Despite a 61-year streak of increasing dividends, CL's EPS growth has been stagnant, leading to a higher payout ratio. Increased advertising expenditures, particularly in digital, have shown higher ROI than traditional channels.
Is Colgate Stock a Buy, Hold or Sell at 24.29X P/E Multiple?
CL counters macro pressures with premium innovations and enhanced advertising to strengthen its market position.
Why Colgate-Palmolive (CL) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Colgate Gains 21.3% YTD: What Makes the Stock Apt to Retain?
CL benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
Colgate-Palmolive Company (CL) Morgan Stanley Global Consumer & Retail Conference - (Transcript)
Colgate-Palmolive Company (NYSE:CL ) Morgan Stanley Global Consumer & Retail Conference Call December 3, 2024 11:45 AM ET Company Participants Stanley Sutula III - Chief Financial Officer Panagiotis Tsourapas - Group President, Europe and Developing Markets Conference Call Participants Dara Mohsenian - Morgan Stanley Dara Mohsenian Good morning, everyone. I'm Dara Mohsenian, Morgan Stanley's Household Products and Beverage Analyst.
